Nanoparticles functionalized with anti-HER2 Abs or its fragments can be effectively used for specific delivery of therapeutic agents to HER2-overexpressed tumor cells by the HER2 receptor-mediated endocytosis process [83] which enhances therapeutic efficacy with fewer side effects. This evidence concerns the gene ERBB2 and neoplasm.